Detection and Quantification of Acrylamide in Second Trimester Amniotic Fluid Using a Novel LC-MS/MS Technique to Determine Whether High Acrylamide Content during Pregnancy Is Associated with Fetal Growth.
Nikolaos DrakoulisNikolaos LoukasNikolaos AntonakopoulosNiki C MaragouMarios G KostakisAliki TsakniDionysios VrachnisDespina VougiouklakiNikolaos MachairiotisArhodoula ChatzilazarouDimitra HouhoulaRozeta SokouSofoklis StavrosPeter DrakakisGeorge MastorakosZoi IliodromitiPublished in: Biology (2023)
Detection of acrylamide in early second trimester amniotic fluid, for the first time in the literature to our knowledge, raises concerns about fetal health, given that published data on animal studies have attributed a number of birth defects to acrylamide. Our novel LC-MS/MS method for the determination of acrylamide in amniotic fluid proved to be effective and its performance in practice was very accurate, simple, and fast. Validation of the method revealed that the use of a matrix-matched curve is necessary for the quantification.
Keyphrases
- healthcare
- umbilical cord
- gestational age
- preterm birth
- public health
- systematic review
- loop mediated isothermal amplification
- primary care
- pregnancy outcomes
- mesenchymal stem cells
- high resolution
- label free
- randomized controlled trial
- electronic health record
- simultaneous determination
- sensitive detection
- health promotion
- clinical evaluation